GlobalData sees ‘revolution’ in obesity treatment
Over 100 products are in active clinical development for obesity, and 66 biotech and pharma companies are involved in obesity clinical trials, according to a new GlobalData report.
CDR
Alvotech and Dr. Reddy’s partner to commercialize biosimilar candidate to Prolia & Xgeva
Alvotech and Dr. Reddy’s Laboratories SA have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia and Xgeva (denosumab). The collaboration combines Dr.
CVS launches Well Market private label snacks
CVS Pharmacy has debuted Well Market, a store brand consumables line featuring nutritious snacks, beverages and groceries. “Our goal at CVS Health is to be the most consumer-centric health care solutions company,” said chief merchandising officer Musab Balbale.
The lessons of Walmart Health’s closure
The sudden, unexpected demise of Walmart Health marks the end of one phase of the retailer’s drive to enhance access to care, improve patient outcomes and lower costs, and the beginning of a more pharmacy-centric approach to achieving many of the same objectives.
Food is Medicine’s place at pharmacies
“You are what you eat.” We know that diet is a vital contributor to health. And now, new funding pathways from both the public and private sector are fueling even more momentum for Food is Medicine programs.
CVS’ first quarter sales and profits fall short of estimates
CVS Health reported first quarter revenue and earnings that missed Wall Street’s estimates, as increased medical costs hurt its Medicare Advantage business. Adjusted earnings per share for the period were $1.33, well behind analysts’ consensus forecast of $1.69. Revenue of $88.
CVS prototype fosters tighter bond with shoppers
CVS Pharmacy’s new prototype store here has a fine-tuned mix, recast physical space, and rebalance of everyday-low pricing and promotions. The format strives to enhance the customer experience, and it does so in large part by centralizing the personnel.
Purpose-driven brands connect with consumers
Having a strong brand purpose and connection with your target consumer is more critical than ever before. Distinct from “social purpose,” a truly purpose-driven brand’s mission should be obsessed with satisfying every category and/or target audience’s unmet needs.
Wentworth sets stage to revitalize WBA
Expect to see further significant changes at Walgreens Boots Alliance in the days ahead.
Palm Beach is the place to be this month
It happens every spring. As April winds down, the National Association of Chain Drug Stores once again convenes its fabled and nearly flawless Annual Meeting. Once again, upwards of 2,000 retailer and supplier executives will gather in Palm Beach, Fla.
Nestlé, Dr. Reddy’s partner to establish nutraceutical supplier in India
Nestlé India Ltd. and Dr. Reddy’s Laboratories Ltd. have formed a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories.
Aurigene and Vipergen partner to offer DNA encoded library (DEL) screening and integrated drug discovery service
Aurigene Pharmaceutical Services Ltd.
Andrea Harrison leaves CVS
CVS vice president of merchandising for beauty and personal care Andrea Harrison has left the company for “a new opportunity,” she wrote on LinkedIn. After 19 years with CVS, “it was a bittersweet departure with so many memories and so hard leaving an amazing team,” she wrote.
Bayer and Dr. Reddy’s ink deal to market, distribute second brand of vericiguat in India
Dr. Reddy’s Laboratories Ltd. and Bayer have partnered to market and distribute a second brand of vericiguat in India. Under the terms of their agreement, Bayer has granted nonexclusive rights to Dr. Reddy’s under the brand name Gantra.
WBA beats estimates for Q2 sales and profits
Walgreens Boots Alliance Inc. topped analysts’ forecasts for second quarter revenue and adjusted earnings. WBA posted adjusted earnings per share of $1.20, well above Wall Street’s predicted 82 cents. Sales of $37.05 billion exceeded the estimated $36.22 billion. The company posted a net loss of $5.